Petersdorf, E. W., Malkki, M., Hsu, K., Bardy, P., Cesbron, A., Dickinson, A., Dubois, V., Fleischhauer, K., Kawase, T., Madrigal, A., Morishima, Y., Shaw, B., Spellman, S., Spierings, E., Stern, M., Tiercy, J. M., Velardi, A., Gooley, T., Int Histocompatibility Working, Grp (2013) 16th IHIW: International Histocompatibility Working Group in Hematopoietic Cell Transplantation. INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 40 (1). pp. 2-10. ISSN 1744-3121

Full text not available from this repository.

Abstract

The International Histocompatibility Working Group is a collaborative international effort to understand the HLA and non-HLA genetics of the transplantation barrier. The Working Group is comprised of experts in the fields of histocompatibility and immunogenetics, hematopoietic cell transplantation and outcomes research. Data for 25855 unrelated donor transplants were submitted in support of research studies for the 16th International Histocompatibility Workshop. Active investigation is in progress in seven key areas: the impact of HLA matching, role of race and ethnicity, identification of permissible HLA mismatches, haplotype-associated determinants, minor histocompatibility antigens, immune response genes and KIR genetics. New hypotheses for the 16th workshop were developed for immunogenetic studies in cord blood and haploidentical-related donor transplantation.

Item Type:	Article
Authors (ICR Faculty only):	Shaw, Bronwen
All Authors:	Petersdorf, E. W., Malkki, M., Hsu, K., Bardy, P., Cesbron, A., Dickinson, A., Dubois, V., Fleischhauer, K., Kawase, T., Madrigal, A., Morishima, Y., Shaw, B., Spellman, S., Spierings, E., Stern, M., Tiercy, J. M., Velardi, A., Gooley, T., Int Histocompatibility Working, Grp
Additional Information:	ISI Document Delivery No.: 070EE Times Cited: 0 Cited Reference Count: 15 Petersdorf, E. W. Malkki, M. Hsu, K. Bardy, P. Cesbron, A. Dickinson, A. Dubois, V. Fleischhauer, K. Kawase, T. Madrigal, A. Morishima, Y. Shaw, B. Spellman, S. Spierings, E. Stern, M. Tiercy, J. -M. Velardi, A. Gooley, T. National Institutes of Health, USA [AI069197]; National Cancer Institute (NCI) [U24-CA76518]; National Heart, Lung and Blood Institute (NHLBI); National Institute of Allergy and Infectious Diseases (NIAID); Health Resources and Services Administration (HRSA/DHHS) [HHSH234200637015C]; Office of Naval Research [N00014-10-1-0204, N00014-1-1-0339] The Coordinating Laboratories at the Fred Hutchinson Cancer Research Center, Seattle and Memorial Sloan Kettering Cancer Center, New York, are supported by grant AI069197 from the National Institutes of Health, USA. CIBMTR is supported by Public Health Service Grant/Cooperative Agreement U24-CA76518 from the National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases (NIAID); a contract HHSH234200637015C with Health Resources and Services Administration (HRSA/DHHS); two Grants N00014-10-1-0204 and N00014-1-1-0339 from the Office of Naval Research. The views expressed in this article do not reflect the official policy or position of the National Institute of Health, the Department of the Navy, the Department of Defense, or any other agency of the U.S. Government. Wiley-blackwell Hoboken Si
Uncontrolled Keywords:	cord blood transplantation hematologic malignancy acute gvhd hla-c donor polymorphisms recipients relapse hla-dpb1
Research teams:	Closed research groups > Translational studies in Haematopoietic Stem Cell Transplantation
Depositing User:	Alexander Smithson
Date Deposited:	18 Feb 2013 17:40
Last Modified:	25 Sep 2014 10:56
URI:	http://publications.icr.ac.uk/id/eprint/12249

Actions (login required)

View Item